NO175188C - Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol - Google Patents

Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Info

Publication number
NO175188C
NO175188C NO902871A NO902871A NO175188C NO 175188 C NO175188 C NO 175188C NO 902871 A NO902871 A NO 902871A NO 902871 A NO902871 A NO 902871A NO 175188 C NO175188 C NO 175188C
Authority
NO
Norway
Prior art keywords
preparing
ability
peptide conjugate
cell cytosol
penetrate cell
Prior art date
Application number
NO902871A
Other languages
Norwegian (no)
Other versions
NO902871L (en
NO175188B (en
NO902871D0 (en
Inventor
Sjur Olsnes
Original Assignee
Sjur Olsnes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sjur Olsnes filed Critical Sjur Olsnes
Priority to NO902871A priority Critical patent/NO175188C/en
Publication of NO902871D0 publication Critical patent/NO902871D0/en
Priority to CA002086342A priority patent/CA2086342A1/en
Priority to JP3510777A priority patent/JPH06503552A/en
Priority to EP91911315A priority patent/EP0542756A1/en
Priority to AU80001/91A priority patent/AU653158C/en
Priority to HU924125A priority patent/HUT63061A/en
Priority to PCT/NO1991/000093 priority patent/WO1992000099A1/en
Publication of NO902871L publication Critical patent/NO902871L/en
Priority to FI925869A priority patent/FI925869A0/en
Priority to LTIP835A priority patent/LTIP835A/en
Publication of NO175188B publication Critical patent/NO175188B/no
Publication of NO175188C publication Critical patent/NO175188C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO902871A 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol NO175188C (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
PCT/NO1991/000093 WO1992000099A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
AU80001/91A AU653158C (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
JP3510777A JPH06503552A (en) 1990-06-27 1991-06-26 How to introduce peptides into the cytosol
EP91911315A EP0542756A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into the cytosol
CA002086342A CA2086342A1 (en) 1990-06-27 1991-06-26 Method of introducing a peptide into a cytosol
HU924125A HUT63061A (en) 1990-06-27 1991-06-26 Process for entering peptide in cytosol
FI925869A FI925869A0 (en) 1990-06-27 1992-12-23 FOERFARANDE FOER INFOERANDE AV EN PEPTID I CYTOSOL
LTIP835A LTIP835A (en) 1990-06-27 1993-08-03 Method of introducting a peptide into the cytosol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Publications (4)

Publication Number Publication Date
NO902871D0 NO902871D0 (en) 1990-06-27
NO902871L NO902871L (en) 1991-12-30
NO175188B NO175188B (en) 1994-06-06
NO175188C true NO175188C (en) 1994-09-14

Family

ID=19893304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902871A NO175188C (en) 1990-06-27 1990-06-27 Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol

Country Status (8)

Country Link
EP (1) EP0542756A1 (en)
JP (1) JPH06503552A (en)
CA (1) CA2086342A1 (en)
FI (1) FI925869A0 (en)
HU (1) HUT63061A (en)
LT (1) LTIP835A (en)
NO (1) NO175188C (en)
WO (1) WO1992000099A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
ES2290950T3 (en) * 1992-04-21 2008-02-16 Institut Pasteur RECOMBINANT MUTANTS TO INDUCE SPECIFIC IMMUNE RESPONSES.
US5935580A (en) * 1992-04-21 1999-08-10 Institut Pasteur Recombinant mutants for inducing specific immune responses
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US6777546B2 (en) 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
US7422747B2 (en) 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
US6004815A (en) * 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
WO2001055169A1 (en) * 2000-01-27 2001-08-02 Loma Linda University Transgenic plant-based vaccines
EP1188446B1 (en) 2000-09-15 2009-08-05 Institut Pasteur Proteinaceous vectors for molecule delivery to CD11b expressing cells
GB0524408D0 (en) * 2005-11-30 2006-01-11 Glaxosmithkline Biolog Sa Vaccines
KR102430891B1 (en) * 2016-03-10 2022-08-09 더 존스 홉킨스 유니버시티 Method for preparing aggregate-free monomeric diphtheria toxin fusion protein and therapeutic use
US11965009B2 (en) 2016-03-10 2024-04-23 The Johns Hopkins University Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369466D1 (en) * 1982-05-12 1987-03-05 Harvard College Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof
FR2532850B1 (en) * 1982-09-15 1985-12-20 Pasteur Institut IMMUNOGENIC CONJUGATES BETWEEN A HAPTENA AND A CARRIER MOLECULE DERIVED FROM A TOXIN, THE VACCINES CONTAINING THEM AND PROCESS FOR OBTAINING THEM
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
IL89504A0 (en) * 1988-03-08 1989-09-10 Univ Wyoming Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
JPH05502880A (en) * 1989-12-22 1993-05-20 セラジェン・インコーポレーテッド Hybrid molecule with a translocation region and a cell binding region

Also Published As

Publication number Publication date
EP0542756A1 (en) 1993-05-26
NO902871L (en) 1991-12-30
LTIP835A (en) 1995-02-27
AU653158B2 (en) 1994-09-22
HU9204125D0 (en) 1993-04-28
WO1992000099A1 (en) 1992-01-09
FI925869A (en) 1992-12-23
CA2086342A1 (en) 1991-12-28
JPH06503552A (en) 1994-04-21
NO175188B (en) 1994-06-06
NO902871D0 (en) 1990-06-27
FI925869A0 (en) 1992-12-23
AU8000191A (en) 1992-01-23
HUT63061A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
NO175188C (en) Process for Preparing a Peptide Conjugate with the ability to penetrate cell cytosol
MY8700015A (en) Two-zone bed combustion/gasification
AU8053687A (en) Improved photovoltaic heterojunction structures
DE68922314D1 (en) SYNERGIC FUEL COMPOSITION.
PT85904A (en) Process for the preparing peptide derivatives
AU1767476A (en) Manifold for solar collector
EP0408252A3 (en) Heterojunction bipolar transistor
GB8824937D0 (en) Fuel injection line for i c engine & process for production thereof
ES8607564A1 (en) Antibodies to human interleukin-2 induced by synthetic polypeptides.
EP0452143A3 (en) Process for preparing optically active 3-hydroxypyrrolidine derivatives
ITTO910894A1 (en) "A PROCEDURE TO PREPARE DIPEPTIDES".
DE68907938D1 (en) CONTAINER FOR CELL CULTURES.
ATA395977A (en) Process for the preparation of dideoxyinosine by deamination of dideoxyadenosine
AR243380A1 (en) A procedure for preparing an antibiotic compound soluble in water, and the procedure for obtaining cefem salts to be applied to these compounds.
PT70309A (en) Process for preparing pharmacologically active phenyl-quinolizidines
IL61702A0 (en) Pharmacologically active peptides
IL61700A0 (en) Pharmacologically active peptides
ES456243A1 (en) 3-Substituted-4-aminoalkoxy-5,6-condensed ring-2-pyranones
IL61701A0 (en) Pharmacologically active peptides
EP0252951A4 (en) Technetium-antibody conjugate.
GB2058452B (en) Hetero-junction photovoltaic cell
DE3786524D1 (en) HORIZONTAL DEFLECTION WITH GRID CORRECTION.
PH25364A (en) Mutant resistant to cell membrane synthesis inhibitor, process for preparing the same
JPS5631970A (en) Pillarrfitted washer with no arm tie
GB2185755B (en) Sold fuel briquettes